Govt to detail 2 bln euros of healthcare savings in Sept * Industry says has already been hit hard * More hurdles for reimbursing drugs seen likely * French biotechs to gain from pro-growth focus By Elena Berton PARIS, July…
See more ›
Monthly Archives: July 2012
Drugmakers brace for more pain, some gain in France
New Call for Proposals: 8 Billion-Euro Research Call Has Been Launched
On July 9, the European Commission announced the biggest ever set of calls for proposals for research under its Seventh Framework Program (FP7), with a total of 8.1 billion euros. The funding is open to individuals, organizations and businesses in…
See more ›
Posted in Latests News and Alerts
GenKyoTex S.A. Raises $26 Million for Phase II Development of Diabetic Nephropathy Drug
GENEVA & ARCHAMPS, France, Jul 09, 2012 (BUSINESS WIRE) — –Funding to Advance First in Class NOX Inhibitor GKT137831 through Phase II Genkyotex, the leading developer of NOX inhibitors to treat oxygen-radical mediated diseases, announced today the closing of a…
See more ›
Posted in Latests News and Alerts
Biotech Company Grows Faster with the Help of SBA Programs
Source: SBA web site Hervé Le Calvez, Ph.D., Founder and CEO, of Abbiotec, LLC, a biotech company developing life science tools for the research market, started his business in 2007. He was well prepared with a Ph.D. in Cellular Biology…
See more ›
Posted in Latests News and Alerts
Newsletter
Facebook
LinkedIn
Twitter
Picasa
Flickr
YouTube
